These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34042306)

  • 21. Patients with seronegative RA have more inflammatory activity compared with patients with seropositive RA in an inception cohort of DMARD-naïve patients classified according to the 2010 ACR/EULAR criteria.
    Nordberg LB; Lillegraven S; Lie E; Aga AB; Olsen IC; Hammer HB; Uhlig T; Jonsson MK; van der Heijde D; Kvien TK; Haavardsholm EA;
    Ann Rheum Dis; 2017 Feb; 76(2):341-345. PubMed ID: 27094444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Five-year favorable outcome of patients with early rheumatoid arthritis in the 2000s: data from the ESPOIR cohort.
    Combe B; Rincheval N; Benessiano J; Berenbaum F; Cantagrel A; Daurès JP; Dougados M; Fardellone P; Fautrel B; Flipo RM; Goupille P; Guillemin F; Le Loët X; Logeart I; Mariette X; Meyer O; Ravaud P; Saraux A; Schaeverbeke T; Sibilia J
    J Rheumatol; 2013 Oct; 40(10):1650-7. PubMed ID: 23950185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thyroid disorders in patients with newly diagnosed rheumatoid arthritis is associated with poor initial treatment response evaluated by disease activity score in 28 joints-C-reactive protein (DAS28-CRP): An observational cohort study.
    Emamifar A; Hangaard J; Jensen Hansen IM
    Medicine (Baltimore); 2017 Oct; 96(43):e8357. PubMed ID: 29069018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High titers of both rheumatoid factor and anti-CCP antibodies at baseline in patients with rheumatoid arthritis are associated with increased circulating baseline TNF level, low drug levels, and reduced clinical responses: a post hoc analysis of the RISING study.
    Takeuchi T; Miyasaka N; Inui T; Yano T; Yoshinari T; Abe T; Koike T
    Arthritis Res Ther; 2017 Sep; 19(1):194. PubMed ID: 28865493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biologic disease-modifying anti-rheumatic drugs and the risk of non-vertebral osteoporotic fractures in patients with rheumatoid arthritis aged 50 years and over.
    Roussy JP; Bessette L; Bernatsky S; Rahme E; Lachaine J
    Osteoporos Int; 2013 Sep; 24(9):2483-92. PubMed ID: 23504029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of anti cyclic citrullinated peptide antibodies in Malaysian rheumatoid arthritis patients and its correlation with disease activity.
    Sockalingam S; Khuan CS; Sthaneshwar P
    Int J Rheum Dis; 2009 Sep; 12(3):211-5. PubMed ID: 20374348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Disease-modifying treatment for inflammatory rheumatism in sub-Saharan Africa: outcome at 6 months of 205 Senegalese patients with rheumatoid arthritis].
    Ndongo S; Pouye A; Lekpa FK; Bihéhé DM; Tiendrebeogo J; Ndao AC; Ka MM; Moreira Diop T
    Med Sante Trop; 2012; 22(4):385-9. PubMed ID: 23352953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis.
    Rantapää-Dahlqvist S; de Jong BA; Berglin E; Hallmans G; Wadell G; Stenlund H; Sundin U; van Venrooij WJ
    Arthritis Rheum; 2003 Oct; 48(10):2741-9. PubMed ID: 14558078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence, sociodemographic factors and treatment penetration of rheumatoid arthritis and psoriatic arthritis in Norway.
    Kerola AM; Sexton J; Wibetoe G; Rollefstad S; Crowson CS; Mars N; Kazemi A; Haavardsholm EA; Kvien TK; Semb AG
    Semin Arthritis Rheum; 2021 Oct; 51(5):1081-1088. PubMed ID: 34450506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence of Diagnostic and Treatment Delay in Seronegative Rheumatoid Arthritis: Missing the Window of Opportunity.
    Coffey CM; Crowson CS; Myasoedova E; Matteson EL; Davis JM
    Mayo Clin Proc; 2019 Nov; 94(11):2241-2248. PubMed ID: 31619364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in use of disease-modifying antirheumatic drugs for rheumatoid arthritis in the United States during 1983-2009.
    Kim SC; Yelin E; Tonner C; Solomon DH
    Arthritis Care Res (Hoboken); 2013 Sep; 65(9):1529-33. PubMed ID: 23463543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rheumatoid Arthritis and Risk of Depression in South Korea.
    Jeon KH; Han K; Jung J; Park CI; Eun Y; Shin DW; Kim H
    JAMA Netw Open; 2024 Mar; 7(3):e241139. PubMed ID: 38441894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV/AIDS and rheumatoid arthritis.
    Cunha BM; Mota LM; Pileggi GS; Safe IP; Lacerda MV
    Autoimmun Rev; 2015 May; 14(5):396-400. PubMed ID: 25578483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Examining Time to Initiation of Biologic Disease-modifying Antirheumatic Drugs and Medication Adherence and Persistence Among Texas Medicaid Recipients With Rheumatoid Arthritis.
    Kim G; Barner JC; Rascati K; Richards K
    Clin Ther; 2016 Mar; 38(3):646-54. PubMed ID: 26899313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in total elbow arthroplasty in patients with rheumatoid arthritis receiving disease-modifying antirheumatic drug therapy based on payer status.
    Ahiarakwe U; Zachary Pearson ; Ochuba A; Kim W; Pressman Z; Haft M; Srikumaran U; Best MJ
    J Shoulder Elbow Surg; 2023 Oct; 32(10):2132-2139. PubMed ID: 37348781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations of HLA-DRB1 alleles with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in northern east part of Turkey.
    Uçar F; Çapkin E; Karkucak M; Yücel B; Sönmez M; Alver A; Kaklikkaya N; Tosun M; Alemdaroğlu E; Solak M
    Int J Rheum Dis; 2012 Dec; 15(6):538-45. PubMed ID: 23253237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis.
    Lacaille D; Guh DP; Abrahamowicz M; Anis AH; Esdaile JM
    Arthritis Rheum; 2008 Aug; 59(8):1074-81. PubMed ID: 18668604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology and Treatment of New-Onset and Established Rheumatoid Arthritis in an Insured US Population.
    Crane MM; Juneja M; Allen J; Kurrasch RH; Chu ME; Quattrocchi E; Manson SC; Chang DJ
    Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1646-55. PubMed ID: 26097059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of periodontitis with rheumatoid arthritis: a pilot study.
    Dissick A; Redman RS; Jones M; Rangan BV; Reimold A; Griffiths GR; Mikuls TR; Amdur RL; Richards JS; Kerr GS
    J Periodontol; 2010 Feb; 81(2):223-30. PubMed ID: 20151800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accuracy of Veterans Administration databases for a diagnosis of rheumatoid arthritis.
    Singh JA; Holmgren AR; Noorbaloochi S
    Arthritis Rheum; 2004 Dec; 51(6):952-7. PubMed ID: 15593102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.